These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 26439007)

  • 1. Impact of a decade of successful antiretroviral therapy initiated at HIV-1 seroconversion on blood and rectal reservoirs.
    Malatinkova E; De Spiegelaere W; Bonczkowski P; Kiselinova M; Vervisch K; Trypsteen W; Johnson M; Verhofstede C; de Looze D; Murray C; Kinloch-de Loes S; Vandekerckhove L
    Elife; 2015 Oct; 4():e09115. PubMed ID: 26439007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV type 1 (HIV-1) proviral reservoirs decay continuously under sustained virologic control in HIV-1-infected children who received early treatment.
    Luzuriaga K; Tabak B; Garber M; Chen YH; Ziemniak C; McManus MM; Murray D; Strain MC; Richman DD; Chun TW; Cunningham CK; Persaud D
    J Infect Dis; 2014 Nov; 210(10):1529-38. PubMed ID: 24850788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early and prolonged antiretroviral therapy is associated with an HIV-1-specific T-cell profile comparable to that of long-term non-progressors.
    Cellerai C; Harari A; Stauss H; Yerly S; Geretti AM; Carroll A; Yee T; Ainsworth J; Williams I; Sweeney J; Freedman A; Johnson M; Pantaleo G; Kinloch-de Loes S
    PLoS One; 2011 Apr; 6(4):e18164. PubMed ID: 21483676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined ART started during acute HIV infection protects central memory CD4+ T cells and can induce remission.
    Chéret A; Bacchus-Souffan C; Avettand-Fenoël V; Mélard A; Nembot G; Blanc C; Samri A; Sáez-Cirión A; Hocqueloux L; Lascoux-Combe C; Allavena C; Goujard C; Valantin MA; Leplatois A; Meyer L; Rouzioux C; Autran B;
    J Antimicrob Chemother; 2015 Jul; 70(7):2108-20. PubMed ID: 25900157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term antiretroviral therapy initiated during primary HIV-1 infection is key to achieving both low HIV reservoirs and normal T cell counts.
    Hocqueloux L; Avettand-Fènoël V; Jacquot S; Prazuck T; Legac E; Mélard A; Niang M; Mille C; Le Moal G; Viard JP; Rouzioux C;
    J Antimicrob Chemother; 2013 May; 68(5):1169-78. PubMed ID: 23335199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the Timing of Initiation of Antiretroviral Therapy During Primary HIV-1 Infection on the Decay of Cell-Associated HIV-DNA.
    Laanani M; Ghosn J; Essat A; Melard A; Seng R; Gousset M; Panjo H; Mortier E; Girard PM; Goujard C; Meyer L; Rouzioux C;
    Clin Infect Dis; 2015 Jun; 60(11):1715-21. PubMed ID: 25737374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with a low HIV reservoir in patients with prolonged suppressive antiretroviral therapy.
    Fourati S; Flandre P; Calin R; Carcelain G; Soulie C; Lambert-Niclot S; Maiga A; Ait-Arkoub Z; Tubiana R; Valantin MA; Autran B; Katlama C; Calvez V; Marcelin AG
    J Antimicrob Chemother; 2014 Mar; 69(3):753-6. PubMed ID: 24187041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of long-term antiretroviral therapy interruption and resumption on viral reservoir in HIV-1 infected patients.
    Montserrat M; Plana M; Guardo AC; Andrés C; Climent N; Gallart T; Leal L; Gatell JM; Sánchez-Palomino S; García F
    AIDS; 2017 Aug; 31(13):1895-1897. PubMed ID: 28590333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The sooner, the better: more evidence that early antiretroviral therapy lowers viral reservoirs in HIV-infected infants.
    Li JZ; Gandhi RT
    J Infect Dis; 2014 Nov; 210(10):1519-22. PubMed ID: 24850791
    [No Abstract]   [Full Text] [Related]  

  • 10. Early antiretroviral therapy with raltegravir generates sustained reductions in HIV reservoirs but not lower T-cell activation levels.
    Hey-Cunningham WJ; Murray JM; Natarajan V; Amin J; Moore CL; Emery S; Cooper DA; Zaunders J; Kelleher AD; Koelsch KK;
    AIDS; 2015 May; 29(8):911-9. PubMed ID: 25730509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extraordinary heterogeneity of virological outcomes in patients receiving highly antiretroviral therapy and monitored with the World Health Organization public health approach in sub-saharan Africa and southeast Asia.
    Aghokeng AF; Monleau M; Eymard-Duvernay S; Dagnra A; Kania D; Ngo-Giang-Huong N; Toni TD; Touré-Kane C; Truong LX; Delaporte E; Chaix ML; Peeters M; Ayouba A;
    Clin Infect Dis; 2014 Jan; 58(1):99-109. PubMed ID: 24076968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Antiretroviral Therapy on HIV-1 Persistence: The Case for Early Initiation.
    Hong FF; Mellors JW
    AIDS Rev; 2015; 17(2):71-82. PubMed ID: 26035165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virologic and immunologic effects of adding maraviroc to suppressive antiretroviral therapy in individuals with suboptimal CD4+ T-cell recovery.
    Cillo AR; Hilldorfer BB; Lalama CM; McKinnon JE; Coombs RW; Tenorio AR; Fox L; Gandhi RT; Ribaudo H; Currier JS; Gulick RM; Wilkin TJ; Mellors JW
    AIDS; 2015 Oct; 29(16):2121-9. PubMed ID: 26544577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How does the timing of antiretroviral therapy initiation in acute infection affect HIV reservoirs?
    Ananworanich J; Dubé K; Chomont N
    Curr Opin HIV AIDS; 2015 Jan; 10(1):18-28. PubMed ID: 25415421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early Antiretroviral Therapy in South African Children Reduces HIV-1-Infected Cells and Cell-Associated HIV-1 RNA in Blood Mononuclear Cells.
    van Zyl GU; Bedison MA; van Rensburg AJ; Laughton B; Cotton MF; Mellors JW
    J Infect Dis; 2015 Jul; 212(1):39-43. PubMed ID: 25538273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 RNA and HIV-1 DNA persistence during suppressive ART with PI-based or nevirapine-based regimens.
    Kiselinova M; Geretti AM; Malatinkova E; Vervisch K; Beloukas A; Messiaen P; Bonczkowski P; Trypsteen W; Callens S; Verhofstede C; De Spiegelaere W; Vandekerckhove L
    J Antimicrob Chemother; 2015 Dec; 70(12):3311-6. PubMed ID: 26324076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral T Follicular Helper Cells Are the Major HIV Reservoir within Central Memory CD4 T Cells in Peripheral Blood from Chronically HIV-Infected Individuals on Combination Antiretroviral Therapy.
    Pallikkuth S; Sharkey M; Babic DZ; Gupta S; Stone GW; Fischl MA; Stevenson M; Pahwa S
    J Virol; 2015 Dec; 90(6):2718-28. PubMed ID: 26676775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-Associated HIV-1 DNA and RNA Decay Dynamics During Early Combination Antiretroviral Therapy in HIV-1-Infected Infants.
    Uprety P; Chadwick EG; Rainwater-Lovett K; Ziemniak C; Luzuriaga K; Capparelli EV; Yenokyan G; Persaud D
    Clin Infect Dis; 2015 Dec; 61(12):1862-70. PubMed ID: 26270687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV reservoirs as obstacles and opportunities for an HIV cure.
    Chun TW; Moir S; Fauci AS
    Nat Immunol; 2015 Jun; 16(6):584-9. PubMed ID: 25990814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired Th17 polarization of phenotypically naive CD4(+) T-cells during chronic HIV-1 infection and potential restoration with early ART.
    DaFonseca S; Niessl J; Pouvreau S; Wacleche VS; Gosselin A; Cleret-Buhot A; Bernard N; Tremblay C; Jenabian MA; Routy JP; Ancuta P
    Retrovirology; 2015 Apr; 12():38. PubMed ID: 25924895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.